We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Dynamic Light-Scattering System Provides Microrheology Capabilities

By LabMedica International staff writers
Posted on 08 Oct 2012
A new dynamic light scattering system is bringing unique protein measurement and microrheology capabilities to the market.

Malvern Instruments (Malvern, UK) conducted the global launch of an addition to its Zetasizer family, bringing unique protein measurement and novel microrheology capabilities to this range of dynamic light scattering (DLS) systems. More...
The new high specification Zetasizer Nano ZSP provides enhanced sensitivity and comes with sophisticated software that drives the two new measurement types.

Similar other systems in the range, the Zetasizer Nano ZSP is a single, compact unit. Where the Zetasizer Nano ZSP, however, is unique with performance specifications for both size and zeta potential measurement. One of the most significant applications being the measurement of the zeta potential, or electrophoretic mobility, of proteins. This process is additionally simplified by the inclusion of a new protein mobility measurement type in the software that controls data acquisition, guiding the user through the measurement and evaluates and reports on data quality. The protein mobility measurement package is included with the Zetasizer Nano ZSP instrument as standard.

As well as a range of new protein-specific features, the new version of Zetasizer software, launched together with the Zetasizer Nano ZSP, enables a new type of measurement on the instrument--microrheology. This DLS-based optical technique allows rheologic characterization of weakly-structured and very strain-sensitive materials using only microliter sample volumes. Among its applications are measuring the viscosity of polymer and protein solutions and determining the onset of protein aggregation.

Malvern’s Zetasizer family now includes a full Zetasizer Nano range of systems for characterizing size, molecular weight, and zeta potential measurement; the Zetasizer APS for automated protein size measurements in multiwell plates; and the Zetasizer µV designed for protein size and molecular weight measurements in both cuvette and chromatography modes.

Related Links:

Malvern Instruments




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Hematology Consumables
Bioblood Devices
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.